|
2025-06-11 |
2025-06-10 |
VP
Vente planifiée
|
Weintraub Michael
Administrateur non-exécutif
|
1 000
-1.8%
27,86
71 568 USD
|
1 000
-1.8%
|
27,86
|
100 000 USD
|
|
|
2025-06-11 |
2025-06-10 |
VP
Vente planifiée
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
1 000
-1.8%
28,00
16 296 USD
|
1 000
-1.8%
|
28,00
|
100 000 USD
|
|
|
2025-06-11 |
2025-06-09 |
VP
Vente planifiée
|
Weintraub Michael
Administrateur non-exécutif
|
1 000
-4.9%
27,51
204 444 USD
|
1 000
-4.9%
|
27,51
|
100 000 USD
|
|
|
2025-04-23 |
2025-04-22 |
VP
Vente planifiée
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
1 330
-5.6%
23,70
31 521 USD
|
1 330
-5.6%
|
23,70
|
31 521 USD
|
|
|
2025-04-23 |
2025-04-21 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
260
-2.9%
23,04
5 991 USD
|
260
-2.9%
|
23,04
|
5 991 USD
|
|
|
2025-04-23 |
2025-04-21 |
V
Vente
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
993
-4.0%
23,04
22 881 USD
|
993
-4.0%
|
23,04
|
22 881 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
VanDuyn Amy Beth
SVP, Human Resources
Dirigeant
|
624
-0.5%
23,81
14 856 USD
|
624
-0.5%
|
23,81
|
14 856 USD
|
|
|
2025-04-17 |
2025-04-16 |
VP
Vente planifiée
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
418
-1.7%
23,66
9 890 USD
|
418
-1.7%
|
23,66
|
9 890 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
Indig Chaim
Chief Executive Officer
Administrateur exécutif
|
3 091
-0.2%
23,81
73 588 USD
|
3 091
-0.2%
|
23,81
|
73 588 USD
|
|
|
2025-04-17 |
2025-04-16 |
VP
Vente planifiée
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
2 488
-1.1%
23,66
58 866 USD
|
2 488
-1.1%
|
23,66
|
58 866 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
2 011
-0.9%
23,81
47 876 USD
|
2 011
-0.9%
|
23,81
|
47 876 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
1 845
-0.2%
23,81
43 924 USD
|
1 845
-0.2%
|
23,81
|
43 924 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
864
-0.8%
23,81
20 569 USD
|
864
-0.8%
|
23,81
|
20 569 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
1 213
-0.9%
23,81
28 878 USD
|
1 213
-0.9%
|
23,81
|
28 878 USD
|
|
|
2025-04-17 |
2025-04-15 |
V
Vente
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
314
-1.2%
24,04
7 550 USD
|
314
-1.2%
|
24,04
|
7 550 USD
|
|
|
2025-04-10 |
2025-04-09 |
VP
Vente planifiée
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
4 696
-3.3%
23,23
109 088 USD
|
4 696
-3.3%
|
23,23
|
109 088 USD
|
|
|
2025-04-10 |
2025-04-09 |
VP
Vente planifiée
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
2 802
-9.8%
23,23
65 090 USD
|
2 802
-9.8%
|
23,23
|
65 090 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
96
-1.1%
24,48
2 350 USD
|
96
-1.1%
|
24,48
|
2 350 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
152
-1.6%
23,46
3 565 USD
|
152
-1.6%
|
23,46
|
3 565 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
1 534
-0.7%
24,48
37 545 USD
|
1 534
-0.7%
|
24,48
|
37 545 USD
|
|
